Pamir Ozan
Insider CIK 1834681 · CDXC Chief Financial Officer · ATNF Interim CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NAGE Niagen Bioscience, Inc. | A Award | 2026-06-30 | 2026-07-08 | 4,255 | $2.71 | $11.5K | 11,627 | SEC↗ |
| NAGE Niagen Bioscience, Inc. | A Award deriv | 2026-02-19 | 2026-02-24 | 62,131 | — | $0 | 62,131 | SEC↗ |
| NAGE Niagen Bioscience, Inc. | P Buy | 2025-11-14 | 2025-11-17 | 2,220 | $6.85 | $15.2K | 2,220 | SEC↗ |
| NAGE Niagen Bioscience, Inc. | P Buy | 2025-11-14 | 2025-11-17 | 4,465 | $6.81 | $30.4K | 7,372 | SEC↗ |
| CDXC ChromaDex Corp. | A Award deriv | 2025-02-12 | 2025-02-14 | 17,230 | — | $0 | 17,230 | SEC↗ |
| CDXC ChromaDex Corp. | P Buy | 2024-11-22 | 2024-11-25 | 2,907 | $7.36 | $21.4K | 2,907 | SEC↗ |
| CDXC ChromaDex Corp. | A Award deriv | 2024-10-21 | 2024-10-23 | 146,544 | — | $0 | 146,544 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award deriv | 2023-09-04 | 2023-09-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ATNF 180 Life Sciences Corp. | P Buy | 2023-05-18 | 2023-05-19 | 5,162 | $1.01 | $5.2K | 8,983 | SEC↗ |
| ATNF 180 Life Sciences Corp. | P Buy | 2021-12-10 | 2021-12-13 | 3,800 | $3.87 | $14.7K | 76,408 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award deriv | 2021-02-26 | 2021-03-03 | 180,000 | — | $0 | 180,000 | SEC↗ |